Ocular Therapeutix was incorporated in the state of Delaware in September 2006 under the name I-Therapeutics, Inc. In October 2006, the name was changed to I-Therapeutix, Inc., and in September 2009, it became Ocular Therapeutix.
24 Crosby Drive
Bedford, MA 01730
Phone: 781-357-4000
You can view our Board of Directors by visiting the Board of Directors section of our website here.
You can view our management team by visiting the Management section of our website here.
December 31st.
PricewaterhouseCoopers LLP.
Ocular Therapeutix is traded on the NASDAQ stock exchange under the symbol “OCUL”.
Ocular Therapeutix went public on July 25, 2014.
Shares can be purchased through a stockbroker of your choice.
Ocular Therapeutix does not offer a direct stock purchase plan.
Currently, Ocular Therapeutix does not offer a dividend or a dividend reinvestment program.
Please contact our transfer agent, Computershare, at http://www.computershare.com/investor. Computershare can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
You must send both your old and new addresses to our transfer agent, Computershare, http://www.computershare.com/investor, by U.S. mail. Each stockholder in question must sign the request for an address change.
Quarterly & Annual reports and other investor materials are available under “Financials & Filings” of the “Investors” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov.
You can view our recent press releases by visiting the Press Releases section of our website.
For investor related questions, please send an email to ir@ocutx.com.
Please visit the Investors section of our corporate website and choose the "Email Alerts" icon to be added to the Ocular Therapeutix distribution list.
Please visit Contact Us and fill out our web form.
